Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Khirurgiia (Mosk) ; (9. Vyp. 2): 33-42, 2023.
Article in Russian | MEDLINE | ID: mdl-37682545

ABSTRACT

OBJECTIVE: To evaluate the possibility of integrating tissue perfusion assessment techniques (ICG perfusion and imaging photoplethysmography - iPPG) into the system of intraoperative control points of laparoscopic interventions with a reconstructive component. MATERIALS AND METHODS: Quantitative assessment of ICG fluorescence and iPPG were used during 8 laparoscopically assisted interventions: gastrectomy for gastric cancer (total - 2 and distal - 1) and colorectal resections (left-sided colorectal resections - 4 and right hemicolectomy - 1). RESULTS: Four stages are presented for the assessment of tissue perfusion: initial assessment, before intestine transection, before anastomosis formation, and evaluation of anastomosis. From the point of view of the significance of clinical decision-making, the «before intestine transection¼ stage is of great importance, due to the ease of transferring the resection level to the optimal tissue perfusion zone. CONCLUSION: Integration of tissue perfusion assessment techniques into the system of intraoperative checkpoints is possible and promising.


Subject(s)
Colorectal Neoplasms , Plastic Surgery Procedures , Humans , Anastomosis, Surgical/adverse effects , Clinical Decision-Making , Perfusion/adverse effects
2.
Exp Oncol ; 40(3): 235-238, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30285008

ABSTRACT

AIM: Late radiation injury in the form of radiation-induced fibrosis (RIF) is one of the many complications of radiation therapy. The aim was to evaluate oxygen perfusion in the skin in the area of late radiation injury manifested as RIF in patients with breast cancer. MATERIALS AND METHODS: Based on our first-hand experience in treating late radiation injures of soft tissues in patients with breast cancer, we measured oxygen perfusion of the skin (tсрО2) in the area of late radiation injury using a transcutaneous monitor (oximeter) TCM 400 (Radiometer, Denmark). RESULTS: Partial oxygen pressure tcpO2 in the RIF area in patients with breast cancer didn't show any significant decrease compared to healthy tissue. Mean value of partial oxygen pressure tcpO2 in the RIF area was 42.650 ± 9.178 mmHg, in the healthy tissue it was 45.180 ± 8.025 mmHg. Maximal difference in tcpO2 between the damaged and healthy tissue was 30 mmHg. CONCLUSIONS: Results of the study suggest that there's no significant difference between oxygen perfusion (tcpO2) in the area of RIF and healthy tissue.


Subject(s)
Breast Neoplasms/drug therapy , Breast Neoplasms/radiotherapy , Radiation Injuries/drug therapy , Skin/drug effects , Adult , Aged , Breast Neoplasms/physiopathology , Female , Fibrosis/etiology , Fibrosis/physiopathology , Humans , Male , Middle Aged , Oxygen/administration & dosage , Perfusion , Radiation Injuries/physiopathology , Skin/injuries , Skin/physiopathology , Skin/radiation effects
3.
Bull Exp Biol Med ; 143(3): 363-7, 2007 Mar.
Article in English | MEDLINE | ID: mdl-18225765

ABSTRACT

Intraperitoneal injection of rat IFN-alpha and human IL-2 to rats with experimental endometriosis led to complete regression of endometrioid heterotopies in 50 and 60% cases, respectively. Retention of the endometrioid epithelium resulted in a significant reduction of proliferative activity of its cells, degree of vascularization, and number of macrophages in the leukocytic infiltration of endometrioid heterotopies.


Subject(s)
Endometriosis/drug therapy , Interferon Type I/administration & dosage , Interleukin-2/administration & dosage , Animals , Cell Proliferation/drug effects , Endometriosis/pathology , Endometrium/blood supply , Endometrium/drug effects , Endometrium/pathology , Female , Humans , Immunologic Factors/administration & dosage , Injections, Intraperitoneal , Leukocytes/drug effects , Leukocytes/pathology , Rats , Rats, Wistar , Recombinant Proteins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL